The deubiquitinase activity of A20 is dispensable for NF-κB signaling

EMBO Reports

Volumn 15, Issue 7, 2014, Pages 775-783

  De, Arnab ^a   Dainichi, Teruki ^a   Rathinam, Chozha Vendan ^a   Ghosh, Sankar ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

A20; deubiquitinase; K63 linked ubiquitination; NF B; signal transduction

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD19 ANTIGEN; CD40 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; DEUBIQUITINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN A20; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; CYSTEINE PROTEINASE; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVITY; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEADY STATE; T LYMPHOCYTE; UPREGULATION; ANIMAL; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; GENOTYPE; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MORTALITY; MUTATION; NUCLEOTIDE SEQUENCE; SHOCK; TRANSGENIC MOUSE;

ANIMALS; CYSTEINE ENDOPEPTIDASES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; ENZYME ACTIVATION; GENOTYPE; IMMUNE SYSTEM; IMMUNOPHENOTYPING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, TRANSGENIC; MUTATION; NF-KAPPA B; PHENOTYPE; SHOCK; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-SPECIFIC PROTEASES;

EID: 84903726513     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201338305     Document Type: Article

References (25)

1. Hayden MS, Ghosh S, (2012) NF-kB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26: 203-234
2. Chen ZJ, Sun LJ, (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33: 275-286
3. Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM, (1992) The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 267: 12424-12427
4. Song HY, Rothe M, Goeddel DV, (1996) The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci USA 93: 6721-6725 (Pubitemid 26230376)
5. Jaattela M, Mouritzen H, Elling F, Bastholm L, (1996) A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol 156: 1166-1173 (Pubitemid 26048113)
6. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A, (2000) Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice. Science 289: 2350-2354
7. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, et al, (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5: 1052-1060 (Pubitemid 41057725)
8. Turer EE, Tavares RM, Mortier E, Hitotsumatsu O, Advincula R, Lee B, Shifrin N, Malynn BA, Ma A, (2008) Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20. J Exp Med 205: 451-464 (Pubitemid 351281609)
9. Lu TT, Onizawa M, Hammer GE, Turer EE, Yin Q, Damko E, Agelidis A, Shifrin N, Advincula R, Barrera J, et al, (2013) Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity 38: 896-905
10. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, et al, (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430: 694-699 (Pubitemid 39061687)
11. Ma A, Malynn BA, (2012) A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat Rev Immunol 12: 774-785
12. Lodolce JP, Kolodziej LE, Rhee L, Kariuki SN, Franek BS, McGreal NM, Logsdon MF, Bartulis SJ, Perera MA, Ellis NA, et al, (2010) African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity. J Immunol 184: 7001-7009
13. Evans PC, Ovaa H, Hamon M, Kilshaw PJ, Hamm S, Bauer S, Ploegh HL, Smith TS, (2004) Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 378: 727-734 (Pubitemid 38406847)
14. Shembade N, Ma A, Harhaj EW, (2010) Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327: 1135-1139
15. Komander D, Barford D, (2008) Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem J 409: 77-85
16. Lin SC, Chung JY, Lamothe B, Rajashankar K, Lu M, Lo YC, Lam AY, Darnay BG, Wu H, (2008) Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J Mol Biol 376: 526-540
17. Li L, Hailey DW, Soetandyo N, Li W, Lippincott-Schwartz J, Shu HB, Ye Y, (2008) Localization of A20 to a lysosome-associated compartment and its role in NFkappaB signaling. Biochim Biophys Acta 1783: 1140-1149
18. - lineage choice. Nat Rev Immunol 8: 788-801
19. Rao P, Hayden MS, Long M, Scott ML, West AP, Zhang D, Oeckinghaus A, Lynch C, Hoffmann A, Baltimore D, et al, (2010) IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response. Nature 466: 1115-1119
20. Bosanac I, Wertz IE, Pan B, Yu C, Kusam S, Lam C, Phu L, Phung Q, Maurer B, Arnott D, et al, (2010) Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kappaB signaling. Mol Cell 40: 548-557
21. He KL, Ting AT, (2002) A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol 22: 6034-6045 (Pubitemid 34857824)
22. Skaug B, Chen J, Du F, He J, Ma A, Chen ZJ, (2011) Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell 44: 559-571
23. Tokunaga F, Nishimasu H, Ishitani R, Goto E, Noguchi T, Mio K, Kamei K, Ma A, Iwai K, Nureki O, (2012) Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-kappaB regulation. EMBO J 31: 3856-3870
24. Verhelst K, Carpentier I, Kreike M, Meloni L, Verstrepen L, Kensche T, Dikic I, Beyaert R, (2012) A20 inhibits LUBAC-mediated NF-kappaB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J 31: 3845-3855
25. Tavares RM, Turer EE, Liu CL, Advincula R, Scapini P, Rhee L, Barrera J, Lowell CA, Utz PJ, Malynn BA, et al, (2010) The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33: 181-191